Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

aprevo® Digital Segmentation

K-Number: K231955 · 2023-11-03

Decision Date2023-11-03
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

aprevo® Digital Segmentation is a medical device manufactured by Carlsmed, Inc.. It received FDA 510(k) clearance on 2023-11-03 under approval number K231955. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the aprevo® Digital Segmentation?

aprevo® Digital Segmentation is a medical device that received FDA 510(k) clearance on 2023-11-03. It is manufactured by Carlsmed, Inc.. The 510(k) number is K231955.

When was aprevo® Digital Segmentation approved by the FDA?

aprevo® Digital Segmentation received FDA 510(k) clearance on 2023-11-03, under approval number K231955.

What company makes aprevo® Digital Segmentation?

aprevo® Digital Segmentation is manufactured by Carlsmed, Inc..

What is the FDA product code for aprevo® Digital Segmentation?

The FDA product code for aprevo® Digital Segmentation is QIH.

Other Devices by Carlsmed, Inc.

View all 21 devices →

Related Devices (Code: QIH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.